Prostate cancer decisions — 2024

The Veteran's cause of death is presumed to be due to lung cancer and prostate cancer, which are diseases associated with herbicide exposure in the Republic of Vietnam.

The Veteran's appeals for increased ratings and service connection have been remanded due to the need for additional examinations to assess current symptomatology and etiology.

The Veteran's prostate cancer is denied as there is no evidence of herbicide exposure during service and the condition did not manifest within one year of separation.

The Veteran's claims for an increased rating for prostate cancer and a TDIU are being remanded due to the need for additional development, including obtaining all pertinent VA and private treatment records.

The Veteran's effective date for Dependents' Educational Assistance (DEA) benefits is granted as of October 9, 2018, due to his permanent and total disability from prostate cancer with urinary incontinence.

The Veteran's prostate cancer residuals are now rated at a 40 percent rating, effective October 1, 2015. The previous 100 percent rating was reduced to 20 percent.

The Veteran's prostate cancer residuals were granted a 40% disability rating from June 28, 2016 to the present. The condition required frequent nighttime urination and daytime voiding intervals less than one hour.

The Board has granted service connection for prostate cancer, but remanded the issues of service connection for granulomatous disease and coronary artery disease due to lack of compliance with previous remand directives.

The Board has granted service connection for anxiety disorder with depression, secondary to tinnitus. The other claims have been dismissed.

The claim for service connection for prostate cancer is being remanded due to the need for an examination that complies with the PACT Act requirements and a review of updated VA treatment records.

The Board has dismissed the claims for service connection for diabetes mellitus, type II and prostate cancer, both secondary to herbicide exposure. The appeal is dismissed due to the appellant's death.

The Board has remanded the case due to insufficient medical opinions regarding whether the Veteran's prostate cancer is related to service-connected epididymitis. The case will be returned for further development and an opinion on this issue.

The Veteran's prostate cancer, chronic pain associated with cancer, unspecified anxiety disorder, erectile dysfunction, nocturia, nocturnal hyperhidrosis, and constipation are all granted as service-connected.,Secondary service connection is also granted for the Veteran's disability manifested by chronic pain associated with cancer, unspecified anxiety disorder, erectile dysfunction, nocturia, nocturnal hyperhidrosis, and constipation.

The Board has granted the Appellant's claim for service connection for the cause of the Veteran's death due to exposure to herbicide agents during active duty, specifically at the Naval Construction Battalion Center in Gulfport, Mississippi. Prostate cancer is recognized as a disease presumptively linked to such exposure.

The Veteran withdrew his appeal for a restoration of a 100 percent rating for prostate cancer residuals, and the Board dismissed the case.

The Veteran's prostate cancer is related to radiation exposure in service, and the Board has granted service connection for this condition.

The Veteran's lumbar spine DDD and prostate cancer residuals are rated at 40 percent, effective from July 28, 2023. The rating for the prostate cancer was previously granted prior to this date.

The Board has remanded the claims for prostate cancer and erectile dysfunction due to insufficient evidence regarding the etiology of these conditions, particularly in relation to presumed exposure during service.